In traditional investment settings, due diligence is often driven by financial models, market size estimates, and growth projections. While these tools have value, they frequently overlook a critical dimension in healthcare innovation: clinical reality. Physicians bring a form of insight that cannot be replicated by spreadsheets alone. Their daily exposure to patient outcomes, procedural workflows, and system constraints allows them to identify strengths—and weaknesses—long b

"If a medical technology doesn't solve a problem you’ve personally managed in the OR, why is it anchoring your retirement portfolio?" In the professional landscape of March 2026, the gap between "clinical reality" and "financial speculation" has never been wider. While surgeons manage high-stakes variables with objective data, many physician investors remain passive passengers in their own portfolios—holding "Legacy MedTech" stocks currently being disrupted by the outpatient